Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep929 | Thyroid | ECE2020

No important salivary gland damage following radioiodine remnant ablation

Krcalova Eva , Horacek Jiri , Gabalec Filip , Zak Pavel , Dolezal Jiri

Radioiodine (131I, RAI) has traditionally been used in thyroid cancer treatment but its benefitshould be balanced against possible risks. Among them, salivary gland dysfunction has oftenbeen discussed, although the reported data have been inconsistent. While some authors reported functional changes following higher (mostly cumulative) activities, there have been scarce data on the activity of 3.7 GBq (100 mCi) that is most commonly used for RAI remnant ablation...